(Q38242954)

31 August 2017

1 reference

title

Plasma level monitoring of antipsychotic drugs (English)

2 references

31 August 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A25154

25 March 2022

1 reference

10.2165/00003088-197803010-00002

https://api.crossref.org/works/10.2165/00003088-197803010-00002

25 March 2022

author name string

T. B. Cooper

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A25154

25 March 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=25154

25 March 2022

publication date

1 January 1978

1 reference

Clinical Pharmacokinetics

31 August 2017

published in

1 reference

31 August 2017

volume

3

1 reference

31 August 2017

issue

1

1 reference

31 August 2017

page(s)

14-38

1 reference

Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment

31 August 2017

cites work

1 reference

12 December 2020

Therapeutic effect and plasma level of thioridazine in schizophrenic patients (author's transl)

1 reference

12 December 2020

Gas chromatographic identification of thioridazine in plasma, and a method for routine assay of the drug.

1 reference

12 December 2020

Serum concentration and elimination from serum of thioridazine in psychiatric patients

1 reference

12 December 2020

Relationship of pharmacological models of bioavailability of chlorpromazine with drug and metabolite blood levels

1 reference

12 December 2020

Measurement of thioridazine in blood and urine

1 reference

12 December 2020

Butaperazine dimaleate metabolism

1 reference

12 December 2020

Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels

1 reference

12 December 2020

Thymoleptic and neuroleptic drug plasma levels in psychiatry: current status

1 reference

12 December 2020

Plasma levels of imipramine and desmethylimipramine and antidepressant effect during controlled therapy(author's transl)

1 reference

12 December 2020

Plasma Levels and Clinical Effects of Thioridazine and Thiothixene

1 reference

12 December 2020

Destruction of chlorpromazine during absorption in the rat in vivo and in vitro

1 reference

12 December 2020

Inter-patient variation in chlorpromazine metabolism

1 reference

12 December 2020

Determination of fluphenazine in plasma by ion-pair partition chromatography

1 reference

12 December 2020

Plasma butaperazine levels in long-term chronic non-responding schizophrenics

1 reference

12 December 2020

Factors influencing the metabolism of tricyclic antidepressants. Studies on interactions and first pass elimination

1 reference

12 December 2020

Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions

1 reference

12 December 2020

Plasma levels and half lives of thioridazine and some of its metabolites. I. High doses in young acute schizophrenics

1 reference

12 December 2020

A mass fragmentographic method for the determination of chlorpromazine and two of its active metabolites in human plasma and CSF.

1 reference

12 December 2020

Development of radioimmunoassay for chlorpromazine

1 reference

12 December 2020

Isolation of a possible new metabolite of thioridazine and mesoridazine from human plasma

1 reference

12 December 2020

Drug Interaction: Inhibitory Effect of Neuroleptics on Metabolism of Tricyclic Antidepressants in Man

1 reference

12 December 2020

Distribution of penfluridol in rats and mice

1 reference

12 December 2020

Pharmacokinetic studies on haloperidol in man.

1 reference

12 December 2020

Anodic coulometric detection with a glassy carbon electrode in combination with reversed-phase high-performance liquid chromatography. Determination of blood levels of perphenazine and fluphenazine

1 reference

12 December 2020

The relationship between blood levels of different forms of butaperazine and clinical response

1 reference

12 December 2020

Red blood cell drug binding as a possible mechanism for tranquilization

1 reference

12 December 2020

Analytical and pharmacokinetic studies on butyrophenones

1 reference

12 December 2020

Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. I. Excretion and metabolism of haloperidol and nine related butyrophenone-derivatives in the Wistar rat

1 reference

12 December 2020

More sensitive gas-chromatographic measurement of chlorpromazine in plasma

1 reference

12 December 2020

A method for the gas chromatographic determination of butyrophenones

1 reference

12 December 2020

Letter: Serum-thioridazine levels after different dosage forms

1 reference

12 December 2020

A gas chromatographic method for determining haloperidol. A sensitive procedure for studying serum concentration and pharmacokinetics of haloperidol in patients

1 reference

12 December 2020

Chlorpromazine metabolism. II. Determination of nonconjugated metabolites in blood of schizophrenic patients

1 reference

12 December 2020

Determination of perphenazine and fluphenazine in whole blood by gas chromatography

1 reference

12 December 2020

A fluorometric method for the measurement of butaperazine in human plasma

1 reference

12 December 2020

Relationships among clinical response, extrapyramidal syndrome and plasma chlorpromazine and metabolite ratios

1 reference

12 December 2020

Butaperazine pharmacokinetics. Effect of dosage regimen on steady state blood levels

1 reference

12 December 2020

A gas chromatographic method for the determination of haloperidol in human plasma

1 reference

12 December 2020

The possible role of metabolites in therapeutic response to chlorpromazine treatment

1 reference

12 December 2020

Blood levels of thioridazine and some of its metabolites in psychiatric patients. A preliminary report

1 reference

12 December 2020

Factors affecting chlorpromazine plasma levels in psychiatric patients.

1 reference

12 December 2020

Thioridazine plasma levels and clinical response

1 reference

12 December 2020

Gas-chromatographic methods for the study of chlorpromazine and some of its metabolities in human plasma.

1 reference

12 December 2020

Gas-chromatographic separation of chlorpromazine, diazepam and N-desmethyldiazepam

1 reference

12 December 2020

Mass fragmentography. Identification of chlorpromazine and its metabolites in human blood by a new method

1 reference

12 December 2020

Quantitation of chlorpromazine and its metabolites in human plasma and urine by direct spectrodensitometry of thin-layer chromatograms

1 reference

12 December 2020

Plasma levels and half lives of thioridazine and some of its metabolites. II. Low doses in older psychiatric patients

1 reference

12 December 2020

Effects of conjugated estrogens on plasma butaperazine levels

1 reference

12 December 2020

A method for determination of chlorpromazine in human blood serum

1 reference

12 December 2020

Binding of thioridazine and some of its metabolites to human serum protein and human albumin

1 reference

12 December 2020

The assay of chlorpromazine and metabolites in blood, urine, and other tissues

1 reference

12 December 2020

Detection of chlorpromazine and thioridazine metabolites in human erythrocytes

1 reference

12 December 2020

Determination of phenothiazines in biological samples.

1 reference

12 December 2020

Gas-liquid chromatographic determination of penfluridol in plasma. A new specific technique

1 reference

12 December 2020

The effect of fluphenazine on steady state plasma levels of nortriptyline

1 reference

12 December 2020

Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis

1 reference

12 December 2020

Influence of the antiparkinsonian drugs on the plasma level of neuroleptics

1 reference

12 December 2020

Pharmacokinetics of chlorpromazine after single and chronic dosage

1 reference

12 December 2020

Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas-liquid chromatography with an electron capture detector

1 reference

12 December 2020

The relationship of plasma chlorpromazine to its 7-hydroxy and sulphoxide metabolites in a large population of chronic schizophrenics

1 reference

12 December 2020

Clinical pharmacokinetic studies of perphenazine

1 reference

12 December 2020

Antiparkinsonian drug administration and plasma levels of penfluridol, a new long-acting neuroleptic

1 reference

12 December 2020

Determination of Thioxanthenes in Plasma at Therapeutic Concentrations

1 reference

12 December 2020

GLC analysis of thioridazine, mesoridazine, and their metabolites

1 reference

12 December 2020

Assay of 7-hydroxychlorpromazine, and failure to detect more than small quantities, in plasma of responding schizophrenics

1 reference

12 December 2020

Prediction of response to chlorpromazine treatment in schizophrenics

1 reference

12 December 2020

Letter: The effect of benztropine mesylate on plasma levels of butaperazine maleate.

1 reference

12 December 2020

Chlorpromazine metabolism in humans. Part I. Quantitation of chlorpromazine and its metabolites in human plasma and urine by direct scan spectrodensitometry

1 reference

12 December 2020

Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment

1 reference

12 December 2020

Chlorpromazine Metabolism IV: Quaternization as a Key to Determination of Picomoles of Chlorpromazine and Other Tertiary Amine Drugs

1 reference

12 December 2020

Effects of perphenazine on imipramine metabolism in man

1 reference

12 December 2020

Physiologic and clinical effects of chlorpromazine and their relationship to plasma level

1 reference

12 December 2020

Effect of lithium on gastric emptying and absorption of oral chlorpromazine

1 reference

12 December 2020

Pharmacological implications of microsomal enzyme induction.

1 reference

12 December 2020

Distribution excretion and metabolism of neuroleptics of the butyrophenone type. II. Distribution, excretion and metabolism of haloperidol in Sprague-Dawley rats

1 reference

12 December 2020

Interactions of orphenadrine and phenobarbitone with chlorpromazine: plasma concentrations and effects in man

1 reference

12 December 2020

Effects of mode of management on plasma chlorpromazine in psychiatric patients.

1 reference

12 December 2020

Chlorpromazine Metabolism I: Quantitative Fluorometric Method for 11 Chlorpromazine Metabolites

1 reference

12 December 2020

Modification of chlorpromazine metabolism by some other drugs frequently administered to psychiatric patients.

1 reference

12 December 2020

Perphenazine concentrations in human whole blood. A pilot study during anti-psychotic therapy using different administration forms

1 reference

12 December 2020

Serum levels of thioridazine in psychiatric patients and healthy volunteers

1 reference

12 December 2020

Identification of a metabolite of thioridazine and mesoridazine from human plasma

1 reference

12 December 2020

Chlorpromazine: effects of antacids on its gastrointestinal absorption

1 reference

12 December 2020

Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy

1 reference

12 December 2020

Pharmacokinetics of thiothixene in man

1 reference

12 December 2020

Plasma concentrations of thioridazine in patients with depression. A preliminary report

1 reference

12 December 2020

A method for the fluorimetric determination of thioridazine (Mellaril) or mesoridazine (Lidanil) in plasma

1 reference

12 December 2020

Dystonic reactions following neuroleptics: Time Course and proposed mechanisms

1 reference

12 December 2020

10.2165/00003088-197803010-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1014330833

0 references

1 reference